1. Investigation of the pharmacokinetics of pHLIP conjugates using in vitro and in silico models | Read more
2. Integrating, metal, carbon and nitrogen biochemistry in two types of roadside ecosystems | Read more
3. Glutamate Transport and Nociception | Read more
4. Ancient Microorganisms in Fluid Inclusions in Halite and Gypsum | Read more
5. Lyme Disease Epidemiology | Read more
6. Image Processing to Characterize In Detail the Spatial Properties of Multiple Bacterial Species
within Biofilm | Read more
7. Statistical-Computer Based Technology in Developing a Clinical Decision Support System for Malignant Pleural Effusion Analysis | Read more
8. Characterization of Biofilm Formation on Sensors | Read more
9. Effects of Atrazine Exposure on Genome-wide Expression Levels in
Drosophila melanogaster Females | Read more
10. Biosynthesis of Pseudomonas Quinoline Signal and integration into fatty acid metabolism in Pseudomonas aeruginosa | Read more
11. Use of Engineered Nanovesicles to Investigate Formation and Biological Function of Bacterial Outer Membrane Vesicles | Read More
12. The Genetic Basis to Variation in Male Courtship Song in Drosophila melanogaster | Read more
13. A Microfluidic Fluorescent Cholesterol Biosensor | Read more
Cancer chemotherapy is limited by toxic effects in healthy tissues, motivating the search for targeted drug delivery.We have developed an approach to target acidic solid tumors using the pH-(Low) Insertion Peptide (pHLIP) (Figure 1a). So far we have shown that pHLIP can translocate phalloidin, a membrane-impermeable polar toxin (Log P -2), into cancer cells to inhibit proliferation in vitro (Figure 1b)4. In collaboration with the Mahler lab, work proposed here aim to investigate the pharmacokinetics of pHLIP conjugates using physiologically realistic models based on microscale cell culture analogs (µCCA).
While pHLIP is a promising system, studies in mice revealed the following shortcomings that point to directions of further studies. I will discuss these directions in the context of µCCA collaboration:
(a) Phalloidin is probably not a sufficiently potent cytotoxic agent in vivo.For this reason, we will synthesize pHLIP-conjugates using cytotoxic agents far more potent than phalloidin, such as calicheamicin, auristatin, maytansinoid DM4, and CC-1065/adozelesin analog DC1. Unlike phalloidin (Log P ~ -2), these toxins are lipophilic (Log P ~ 1-5) and membrane-permeable. Attaching pHLIP to these toxins serve two purposes in vivo: (1) pHLIP translocation may circumvent capture of the drug by P-glycoproteins —the drug efflux pumps responsible for multi-drug resistance in cancer cells; and (2) at neutral pH, pHLIP may partition to the cell surface but will not insert, effectively blocking toxin entry into healthy cells (and reducing off-site toxicity). The µCCA model seems the perfect setting for studying the following questions: How does pHLIP attachment alter the metabolic fate of toxin molecules of various lipophilicity (Log P of -3 to 5)? How does the chemical nature of the linker (e.g. disulfide, sterically-hindered disulfide, ester, or azo group) impact the metabolic fate of the toxin cargo in pHLIP conjugates?
(b) Pharmacokinetics of pHLIP monomer is poor. More than 90% of pHLIP peptides are lost within 24 hours. The µCCA model will allow us to probe the metabolic fate of pHLIP and pHLIP-conjugates in more detail (by answering questions such as 'Are pHLIP peptides cleaved during circulation after i.v. injection?' or 'Are pHLIP peptides specifically metabolized by certain cell populations?').
(c) The pHLIP peptide targets acidity in vivo. Thus, acidic tissues other than tumors will also be targeted, such as the kidneys (as we observed), which may lead to toxic side effects in pHLIP-mediated drug delivery. We propose to synthesize pHLIP-PEG conjugates in the size range of ~ 5-10 nm in hydrodynamic diameter (M.W. 30-100 kD). If the µCCA system can accurately model renal filtration (the size of the renal pore is ~ 5 nm), then the pharmacokinetics of pHLIP-PEG conjugates may be investigated.
Faculty Mentors: Gretchen Mahler (Bioengineering) and Ming An (Chemistry)
Graduate Mentor: Courtney Sakolish (Bioengineering)Back to top
For Project I, we have archived soils from a three-year manipulation experiment where plots in an open-field roadside ecosystem next to I-81 had received experimental additions of nitrate, sodium chloride, and water (control). The experiments were conducted by Prof Zhu's lab in the Department of Biological Sciences. Salt input significantly reduced the plant photosynthesis and soil microbial respiration rates. Now we plan to investigate the impact of biogeochemical alterations of C, N, and salt on the downward metal mobility. Soils collected from the experimental plots will be analyzed for major traffic-related metals in Prof. Graney's lab in the Department of Geological Sciences. For Project II, we have ongoing studies in roadside ditches where we have identified contamination of soils by metals (plus high salt content!). Here we plan to investigate whether such contaminated soils from ditches would have reduced C content, microbial activity, and N transformation.
Students will conduct metal analyses (Zn, Cu, Cd, and other selected metals) in the Geology laboratories. They will use microwave digestion to separate metals from the soil matrix and then analyze metal concentrations using the ICP-OES and ICP-MS. In the Biology laboratories, they will analyze N content (particularly nitrate) using the Lachat autoanalyzer, and quantify soil C content and microbial use of C using the GC (gas chromatography). HHMI students will also participate in field work including collecting soils from both the I-81 site and ditches.
Faculty Mentors: Joseph Graney (Geology) and Weixing Zhu (Biology)
Graduate Mentors: Miki Smith (Geology) and Stephanie Craig (Biology)Back to top
Faculty Mentors: Jilla Sabeti (Psychology) and Christof Grewer (Chemistry)
Graduate Mentors: Miguel Cabrea (Psychology) and Rose Tanui (Chemistry)Back to top
Faculty Mentors: Tim Lowenstein (Geology) and J. Koji Lum (Anthropology/Biology)
Graduate Mentors: Sarah Feiner (Geology) and Yue Zhang (Anthropology)Back to top
The Binghamton University (BU) Lyme disease research group is composed of faculty, staff, undergraduate and graduate students. We are currently using the Binghamton University campus as a natural experimental model to study the factors involved in Lyme disease transmission in a small geographically defined area. The project centers on five strategic areas (field ecology, laboratory analysis, field behavioral study, clinical symptomology and mathematical modeling) that are designed to address the factors influencing Lyme disease and other tick-borne infection emergence in human populations in upstate New York and other northeast areas. The field and laboratory component of the project involves the collection of ticks from various microecologies on campus using a corduroy cloth to drag the leaf litter and lower vegetation. Thus far we have collected and tested 411 ticks from the local region, including 310 on the Binghamton University campus of which 210 are larvae that have not yet taken a blood meal and thus not expected to harbor any mouse-borne infectious agents. Total DNA is extracted and the presence of B.burgdorferi, A. phagocytophilum, B. microti, and R. rickettsii is determined by PCR amplification. Demography, human traffic patterns, the built environment and human behaviors are also currently being assessed to determine exposure and risk that will lead to subsequent public health strategies and interventions.
Modeling of Lyme disease risk factors and the Lyme epidemic is a major research component of the project. Modeling of ecological dynamics of Lyme disease is an emerging subfield within the broader context of Lyme disease epidemiology. Models relating to vector-host-environment interactions are at the core of understanding the interrelating variables involved in disease transmission to humans. Clinical diagnosis of Lyme disease is heavily reliant on serologic and objective testing and doesn't necessarily incorporate ecological factors. Current Lyme disease laboratory diagnostic measures can be subject to error as well as untimely with a window of effectiveness which peaks four weeks after infection. We propose utilizing variables derived from existing models combined with epidemiological, ecological, social and behavioral factors to formulate a standardized algorithm of risk for use at the clinician level.
The methodological approach involves variables used in ecological models for predicting spatial distribution of disease-causing ticks. The variables include geographical location, annual precipitation, temperature, vegetation, land-use patterns and season. These ecological variables will be combined with a mathematical/computational dynamical model of spatial distribution of ticks as well as other epidemiological variables of age, sex, occupation and recreational habits. In addition, local incidence and engagement in risk prone activities will be integrated into the model. These variables will be weighted according to their predictive value in the models and combined to yield a composite score. The score will be normalized against a scale of 0 to 10 where 0 indicates the least risk and 10 indicates the maximum risk of infection. We expect that individuals with scores approaching 10 will be at the highest risk for being exposed to the pathogen that causes Lyme disease, Borrelia burgdoferi, while those scoring low will be at minimal risk.
Assigning risk scores to individual patients is important in determining further diagnostic or treatment protocols for a significant number of patients who do not present with classic Lyme disease symptoms and objective findings. Such a tool would add to the diagnostic armamentarium in Lyme disease detection and potentially speed the diagnosis and treatment of patients outside the classic presentation of Lyme disease. Investigative research will need to be conducted regarding the importance of each variable in the incidence of Lyme disease. This will allow for a more accurate scoring model when assessing a variable's weight of risk with respect to one another.
Faculty Mentors: Ralph Garruto (Anthropology) and Hiroki Sayama (Bioengineering)
Graduate Mentors: John Darcy (Anthropology) and Jeff Schmidt (Bioengineering)Back to top
The proposed research will investigate the dynamics of the multi species biofilm populations within Eukaryotic epithelial cell lines. Microbial infections, including nosocomial infections are mainly caused by multi-species bacterial populations. However, the available treatments are based on studies of single species bacterial populations. Currently not much is known about the initial stages of infection and how several bacterial species interact and eventually develop into biofilm within a Eukaryotic cell. Understanding the development of mixed species biofilms within epithelial cells could lead to a significant improvement on the efficacy of the treatment of infections.
This research will involve the tracking of individual cells to better understand the mechanisms by which they attach to a Eukaryotic cell and the interaction of the two bacterial species within the biofilm population and with the epithelial cells. Biofilms composed of Pseudomonas aeruginosa and Staphylococcus aureus will be used to co-infect Eukaryoticepithelial cells. We will monitor, by microscopy, the development of the biofilms throughout the infection of the Eukaryotic cells. Image processing, estimation and optimal hypothesis testing algorithms will be employed to accurately estimate population density and distribution of different bacterial species in the spatial domain and to develop a predictive model for the effect of local population density of one species versus another. This includes the continued development of a software product for analyzing bulk image sets acquired using confocal microscopy. Once the basic methods are established further research will be done to establish the efficacy of certain antimicrobials in biofilm killing and the change in shifts in population dynamics occurring throughout the treatments.
Faculty Mentors: Claudia Marques (Biology) and Scott Craver (Electrical and Computer Engineering)
Graduate Mentors: Alireza Farrokh-Baroughi (Electrical and Computer Engineering) and Aleksey Morozov (Biology)Back to top
The HHMI research project brings together Research Professor Walker Land , Dave Schaffer , Xingye Qiao, Dr. Sidhu , Chris Paquette and Martha Nelson who have been and are developing statistical learning theory (SLT) paradigms that result in complex adaptive systems (CAS), which measure the efficacy of drug treatments, survivability analysis of patients with operable metastatic lung cancer, and developing methods to intelligently process covariant features to accurately ascertain efficacy of new biomedical density measurements as applied to cancer screening and diagnosis. Specifically this project involves developing a Clinical Decision Support System (CDSS) for Malignant Pleural Effusion Analysis
The purpose of this hypothetical clinical decision support system is to aid clinicians in making the correct diagnosis in situations where malignancy may be a likely cause of patient symptoms/signs. While the precise clinical question to be answered is unknown this system has the potential to deliver highly accurate information pertaining to the differentiation between malignancy and other causes (diagnosis). The output information can be ideally used by thepathologist as a second opinion to check against their conclusions.
We will rely on our assisting pathologist to aid us in reviewing our system and logic to ensure that we fully understand the question/issue at hand, and more importantly, create a system that can deliver value to both patients and other clinicians. In my brief review, malignant and benign diagnosis seem to be the only situations under investigation in the academic realm. The assistant pathologist will provide us with critiques on what features we should consider in our system, what disease we should focus on, how the flow of our system will impact work-flow in clinical settings, and whether our system is scalable—just to name a few.
Faculty Mentors: Walker Land (Bioengineering), David Schaffer (Bioengineering) Xingye Qiao (Mathematics)
Graduate Mentor: Yinglei Li (Bioengineering)Back to top
Faculty Mentors: Karin Sauer (Biology) and Wayne Jones (Chemistry)
Graduate Mentors: Yi Li (Biology) and Megan Fegley (Chemistry)Back to top
Faculty Mentors: Anthony Fiumera (Biology) and Xingye Qiao (Mathematics)
Graduate Mentors:Sarah Marcus (Biology) and Yilin Zhu (Mathematics)Back to top
Bacterial cell-to-cell communication, termed Quorum Sensing (QS), is a system where bacteria secrete small molecule signals into the environment that are then detected by neighboring cells, which respond by altering gene expression and therefore behavior. Many of the gene expression and behavioral changes controlled by QS are found to be associated with bacterial virulence . In the opportunistic human pathogen Pseudomonas aeruginosa, the QS signal PQS not only induces the expression of virulence factors, but also physically promotes the packaging of these factors into Outer Membrane Vesicle (OMV) delivery vehicles for trafficking to target cells . This mode of transport allows pathogens to move disease-causing factors directly to target cells in a manner where they are protected from destruction by the immune system. Understanding the synthesis and function of PQS may therefore provide an exciting avenue toward developing therapies to mitigate P. aeruginosa virulence.
Genetic studies have identified genes involved in PQS biosynthesis and signal recognition . Based upon sequence analysis of these genes, a pathway has been proposed for the synthesis of PQS (Fig 1) . Anthranilate is believed to be condensed in a head-to-head fashion with -keto-decanoyl acid to form HHQ, which is then hydroxylated to form PQS. The route anthranilate takes through the pathway has been explored [3, 7, 8], but the reactions (and even the source) of the fatty acid substrates remain poorly understood. The question becomes even more interesting when one realizes that more genes exist in the biosynthetic gene cluster than are necessary for the synthesis of PQS. PqsD, PqsB and PqsC share sequence homology with one another and have been suggested to carry out condensation and fatty-acyl-carrier functions. However, as Fig 1 indicates, a maximum of two such proteins would be necessary to synthesize PQS. As few as one protein could be required for this since fatty-acyl-condensing enzymes often also function as carriers. This project proposes genetic experiments combining knockouts of pqsB, pqsC and pqsD in combination with disruptions in known sources of β-keto-fatty acids to identify the physiological source of the fatty acid substrate and identify whether the apparent redundancy in carriers reflects biological control over substrate flux from different sources. One argument in favor of this hypothesis is the observation that disruption of rhamnolipid synthesis (a potential source of fatty acid) results in partial loss of PQS production . An alternative explanation for the apparent protein redundancy is that the presence of multiple carrier proteins reflects a need for flexibility in the substrates used for PQS biosynthesis. Interestingly, it has been observed that P. aeruginosa naturally secretes two predominant forms of PQS, one with a 7-carbon alkyl substituent and one with a 9-carbon substituent . According to the proposed model for PQS biosynthesis, this would require the ability to use two different fatty acid substrates in the synthesis of PQS. Furthermore, feeding the organism fatty acid synthesis precursors caused it to shift production toward 9-carbon intermediates , suggesting that a control mechanism might exist to selectively produce different PQS analogs in response to the environment. Such control could be exercised through the use of specific carrier proteins for the substrates leading to the 7- and 9-carbon alkyl chain PQS molecules. To test this hypothesis, the proposed project will include the purification of PqsB and PqsC to investigate their specificity for carrying fatty acid substrates of different composition. Another aspect of this section of the project will be to investigate each of the three proteins for condensing activity. While PqsD has been shown convincingly to condense anthraniloyl-CoA with manlonate substrates (very short-chain fatty acids) to form a different secondary metabolite of P. aeruginosa , attempts to show condensation with the long-chain fatty acids required for PQS biosynthesis have resulted in minimal success (catalytic efficiency 5000-fold less than with malonyl-CoA) . Thus, either the true condensing activity for PQS biosynthesis resides in another protein, or previous PqsD studies have not been using the physiologically relevant fatty acid substrate. The proposed work will allow us to test both hypotheses: by looking for condensing activity in PqsB and PqsC as well as PqsD, and by using the PqsB- and PqsC-fatty-acid complexes (likely the true physiological substrates) as substrates for PqsD once their fatty acid specificities have been identified. It is clear that many important questions remain concerning the pathway toward PQS biosynthesis. The proposed project aims to tackle these questions through a combination of genetics and biochemistry. However, the biochemical analysis cannot proceed in the absence of collaboration with a skilled chemist to both synthesize substrates and assist in the characterization of the purified proteins.
To probe the substrate preference of PqsB, PqsC, and PqsD (with regard to carbon chain length), we plan to synthesize various β-keto-acids that (in principle) would give HHQ and PQS with 3, 5, 7 and 9 hydrocarbon side-chains. These enzyme-catalyzed reactions will be monitored via UV-vis spectroscopy and HPLC (by following the formation of HHQ). Ethyl 3-oxohexanoate is commercially available, which upon saponification would provide the β-keto-acid corresponding to the C3 HHQ/PQS product. The syntheses of 3-oxo-octanoic acid (for C5 HHQ/PQS), 3-oxo-decanoic acid (for C7 HHQ/PQS), and 3-oxo-dodecanoic acid (for C9 HHQ/PQS) will be carried out according to published procedures involving the enolate of methyl acetate and the appropriate acyl chlorides, followed by hydrolysis of the esters under basic conditions [1, 7]. To further investigate the mechanism of HHQ formation, we also plan to synthesize CoA and N-acetyl cysteamine thioesters of these β-keto-acids as mimics of the ACP-bound β-keto-acids . These synthetic efforts would also allow us to radiolabel the β-keto-acid substrates if such material is needed for future studies. In short, understanding the mechanism of HHQ/PQS formation will lead to the design and synthesis of enzyme inhibitors as potential antimicrobial agents. Further, elucidating the full biosynthetic pathway will then allow us to enzymatically synthesize a multitude of PQS analogs for functional studies.
Faculty Mentors: Jeffery Schertzer (Biology) and Ming An (Chemistry)
Graduate Mentor: Joab Onyango (Chemistry)
Vesicle-mediated transport was once believed to be an exclusive feature of eukaryotic systems. It is now understood that Gram-negative bacteria also have the ability to sort, package and transport cargo to other cells in vesicles that bud off from their outer membrane (OM). This mode of transport can provide target specificity, allow for concentrated long-distance delivery and provide protection from the environment, including elements of the immune system. As a testament to their versatility and importance, OMVs have been shown to play important roles in the delivery of virulence factors, modulation of the host immune system, bacterial cell-to-cell communication (termed quorum sensing, QS), and the maturation of biofilms. For this reason, it is of great interest to understand how OMVs are formed and the nature of their functions in bacterial physiology and behavior.
In the opportunistic human pathogen Pseudomonas aeruginosa it was shown that the OMV-transported QS signal PQS (Pseudomonas Quinolone Signal) is responsible for inducing the formation of the very OMVs into which it is packaged , even in the absence of its receptor or de novo protein synthesis. This suggested that the OMV-inducing characteristic was based on a physical effect of PQS and not upon its role in altering gene expression as a QS signal. Following this, Dr. Schertzer proposed a mechanism (Fig 1) by which insertion of PQS into the outer leaflet of the outer membrane would expand that leaflet relative to the inner one and thereby induce membrane curvature, eventually leading to bleb formation and finally release of OMVs . This work successfully showed that PQS could induce curvature in model phospholipid membranes, but suffered from the caveat that it could not be tested using artificial membranes matching the asymmetric lipopolysaccharide (LPS) / phospholipid (PL) (outer leaflet / inner leaflet) architecture of the bacterial OM. This was an unfortunate limitation of technology since no such membrane structures have been made at the appropriate size or material scale to test these questions. Dr. Chiarot's nanoscale vesicle technology (below) promises to alleviate this problem, allowing OMVs of controlled size to be fabricated with lipid content and architecture identical to that of the natural OM. The proposed work will use large (bacteria-sized) engineered OMVs to test the applicability of the bilayer-couple model to bacterial surfaces. Nanoscale (50 – 500 nm) OMVs will be used to investigate the preference of PQS to insert into membranes of different curvature (as in ). That PQS might prefer curved membranes is a hypothesis developed in our group to explain the apparent ability of PQS to self-aggregate in the OM to be packaged into OMVs – greater than 80% of PQS in a bacterial culture is associated with OMVs. In addition, by engineering the OMVs to have the opposite asymmetry (LPS = inner, PL = outer), we will use engineered OMVs to screen for compounds that can expand the PL leaflet, which would antagonize natural OMV production and hinder bacterial virulence.
The proposed work also aims to define the role of OMVs in biofilm maturation. Biofilms are communities of bacteria that have attached to a surface and encased themselves in a structural and protective extracellular matrix. In this mode of growth, bacteria more resemble a multicellular tissue than the solitary planktonic cells that they are commonly thought to be. In fact, it is now appreciated that biofilm growth is the common mode of growth for bacteria in nature and biofilm infections make up the majority of bacterial infections. When PQS production is disrupted in P. aeruginosa, the organism fails to form mature biofilms , but it is unclear whether this is due to the loss of the QS function of PQS or the potential structural function of OMVs in the biofilm. Since PQS physically stimulates the formation of OMVs in P. aeruginosa, it is exceedingly difficult to generate natural OMVs that lack PQS to attempt to discriminate between these two functions. In addition to investigating PQS-free OMVs from other species, we will use engineered OMVs to attempt to complement biofilm maturation deficiencies in PQS biosynthetic mutant strains. These OMVs will contain no PQS or bacterial protein and will serve as the perfect 'blank slate' to add back individual components and identify key contributors to biofilm maturation.
The use of microfluidic technology is an attractive option for producing customized synthetic vesicles. This technology has many important advantages, including: precise control over dispensed volumes, high-throughputs, and repeatability. The internal volume of a microfluidic device is on the order of nanoliters, while typical solution flow rates can be as low as picoliters-per-minute. Smaller volumes mean less material (i.e. lipid) is consumed – a significant issue for high-cost lipids such as LPS and a true hurdle overcome using this technique. Most notably, our proposed technique will be capable of building vesicles with asymmetric membranes, where each leaflet is composed of a different lipid. This is an essential requirement for each of the downstream studies.
Our proposed technique uses liquid emulsions and lipid self-assembly inside a microchannel network built using a layer of poly-dimethylsiloxane (PDMS) bonded to a glass substrate with patterned electrodes . This system is ideal for achieving control over vesicle unilamellarity, size, and uniformity. Membrane curvature (proportional to vesicle size) will be tightly controlled, with both narrow and wide OMV size distributions possible. This feature is an excellent fit for downstream applications as both wide distributions (for studying PQS insertion into OMVs of different curvature) and narrow distributions (for biofilm complementation experiments) will be called for. Our strategy for forming vesicles relies on four key steps as shown in Fig 2: (i) emulsion formation using flow focusing, (ii) formation of co-flowing laminar streams (iii) lipid monolayer self-assembly at multiple liquid-liquid interfaces, and (iv) dielectrophoretic steering to transfer lipids to the emulsion surface. Lipid bilayer self-assembly takes place at the surface of the emulsions, which act as a template for the vesicle membrane. The emulsion itself forms the body of the vesicle, while steering of the emulsion using dielectrophoretic force allows the outer leaflet to be "painted" onto the inner leaflet as the emulsion slips through the interface between oil and aqueous phases. Typical emulsion (vesicle) diameters are ~10μm; however, diameters <1μm are achievable with the addition of an electric field to break up larger emulsions. For additional flexibility, the device can be fabricated to allow for the addition of exogenous materials (ie PQS, OMV proteins) prior or subsequent to their formation and also allow for on-chip analysis of the OMVs as they exit.
The proposed microfluidic device provides a flexible, reliable and low cost way to produce vesicles to biological specifications at high throughput. These tailored OMVs will then be used to investigate exciting biological questions that were technically unfeasible even in the recent past.
Faculty Mentors: Jeffery Schertzer (Biology) and Paul Chiarot (Mechanical Engineering)
Graduate Mentors: Alex Nello (Biology) and Li Lu (Mechanical Engineering)Back to top
Understanding the genetic basis to complex behaviors, such as courtship, can help us understand neural development and gene regulatory networks. Using genetic variation present in natural populations to study courtship can also allow us to study how natural selection might affect behavior. This HHMI project brings together Dr. R. Miles, Dr. C. Miles and Dr. A. Fiumera to study the genetic basis to variation in male courtship song in Drosophila melanogaster. This project will survey courtship song from more than 150 genetically distinct D. melanogaster lines that have their full genomes sequenced and genome wide association mapping will be used to identify which genes are affecting song parameters such as frequency or pulse rate.
Faculty Mentors: Anthony Fiumera (Biology), Carol Miles (Biology) and Ron Miles (Mechanical Engineering)
Graduate Mentor: Tim Galati (Mechanical Engineering)Back to top
This project seeks to develop a simple fluorescence based cholesterol biosensor. In place of the enzyme cascade, we will use a single autocatalytic protein that separates into two fragments in the presence of cholesterol. Cholesterol serves as a nucleophile, attacking at a precise location (Gly-Cys) in the protein sequence (Figure 1, left) (Porter et al. 1996). To repurpose this autocatalytic event into a cholesterol biosensor, we will modify the protein with fluorescent probes and immobilization tags so that self-cleavage can be monitored optically in real time. A prototype of the sensing platform, which we will be constructed using nanofabrication technology, is depicted below (Figure 1, right).
Faculty Mentors: Stephen Levy (Physics) and Brian Callahan (Chemistry)
Graduate Mentors: Steven Button (Physics and Timothy Owen (Chemistry)Back to top
Last Updated: 10/7/13